How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Close this folder6 DEVELOPING SPECIFIC INFORMATION SECTIONS
View the documentCreating locally important appendices
Close this folderAdopting appendices from the WHO model formulary
View the documentAdditions
View the documentDeletions
Open this folder and view contentsWorking with a master document in Microsoft Word® to create a table of contents and index
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

Adopting appendices from the WHO model formulary

There are five appendices in the WMF which complement the information on medicines presented in the main sections. These are as follows:

Appendix 1.

Interactions

Appendix 2.

Pregnancy

Appendix 3.

Breastfeeding

Appendix 4.

Renal impairment

Appendix 5.

Hepatic impairment

Each appendix has a general introductory text and a detailed medicine-specific information section.

There are two important steps to be taken during the adoption of appendices:

Step 1. Adoption of the general introductory text of an appendix

It is advisable to copy and maintain the full introductory texts from the WMF for each appendix because they contain universally valid information and instructions on how to use each specific appendix. If it is necessary to add locally important information to the introductory text, this should be distinguished from the rest of the text by using a different text style, as discussed in Chapter 4 for the main sections.


Step 2. Adoption of specific information for individual medicines

In most cases, it is likely that both additions and deletions will be necessary.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014